T. Rowe Price Investment Management, Inc. - KYMERA THERAPEUTICS INC ownership

KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 122 filers reported holding KYMERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of KYMERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,386
-39.5%
1,610,4960.0%0.02%
-36.0%
Q2 2023$37,026
-36.5%
1,610,496
-18.2%
0.02%
-40.5%
Q1 2023$58,318
+19.5%
1,968,175
+0.6%
0.04%
+13.5%
Q4 2022$48,822
-99.9%
1,955,977
-2.0%
0.04%
+5.7%
Q3 2022$43,465,0001,996,5290.04%
Other shareholders
KYMERA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 457,059$9,950,00017.03%
Atlas Venture Life Science Advisors, LLC 6,875,698$149,684,00016.52%
BVF INC/IL 4,692,604$102,158,0004.22%
Aquilo Capital Management, LLC 330,246$7,189,0002.59%
Redmile Group, LLC 2,876,637$62,624,0002.43%
Artal Group S.A. 1,500,000$32,655,0001.39%
Deer Management Co. LLC 615,895$13,408,0000.94%
Avoro Capital Advisors LLC 2,169,230$47,224,0000.87%
AtonRa Partners 34,462$750,0000.74%
Rock Springs Capital Management LP 1,046,743$22,788,0000.59%
View complete list of KYMERA THERAPEUTICS INC shareholders